We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+8.37%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$668M
AUM Growth
+$59M
Cap. Flow
+$14.9M
Cap. Flow %
2.22%
Top 10 Hldgs %
29.86%
Holding
189
New
18
Increased
76
Reduced
37
Closed
11

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$7.74M
2
SBUX icon
Starbucks
SBUX
+$6.67M
3
CVS icon
CVS Health
CVS
+$5.86M
4
XYZ
Block Inc
XYZ
+$3M
5
NKE icon
Nike
NKE
+$2.98M

Sector Composition

Rank Sector Weight
1 Financials 18.01%
2 Healthcare 16.91%
3 Technology 15.96%
4 Consumer Discretionary 12%
5 Industrials 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
151
Walmart Inc
WMT
$881B
$224K 0.03%
+6,801
New +$208K
VEU icon
152
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$219K 0.03%
4,000
TXT icon
153
Textron
TXT
$14.8B
$207K 0.03%
+3,660
New +$199K
MLNT
154
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$204K 0.03%
+2,582
New +$191K
TJX icon
155
TJX Companies
TJX
$174B
$203K 0.03%
+5,300
New +$192K
TYME
156
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$198K 0.03%
+31,000
New +$138K
HPE icon
157
Hewlett Packard
HPE
$66.4B
$187K 0.03%
13,051
+1,001
+8% +$14.2K
FNB icon
158
FNB Corp
FNB
$6.84B
$139K 0.02%
+10,027
New +$138K
ARLZ
159
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$137K 0.02%
96,429
-2,800
-3% -$4.6K
NVLN
160
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$81K 0.01%
26,000
+6,000
+30% +$28.8K
RIGL icon
161
Rigel Pharmaceuticals
RIGL
$686M
$78K 0.01%
2,000
TOVX icon
162
Theriva Biologics
TOVX
$10.4M
$64K 0.01%
14
+8
+133% +$50K
PDLI
163
DELISTED
PDL BioPharma, Inc.
PDLI
$55K 0.01%
20,000
-2,500
-11% -$7.68K
FCSC
164
DELISTED
Fibrocell Science Inc.
FCSC
$11K ﹤0.01%
3,333
SCPX
165
DELISTED
Scorpius Holdings, Inc.
SCPX
0
ACAD icon
166
Acadia Pharmaceuticals
ACAD
$4.39B
-5,400
Closed -$203K
AEO icon
167
American Eagle Outfitters
AEO
$2.99B
-10,000
Closed -$143K
ASRT
168
DELISTED
Assertio
ASRT
-333
Closed -$116K
BTI icon
169
British American Tobacco
BTI
$129B
-3,257
Closed -$203K
CLX icon
170
Clorox
CLX
$11.9B
-31,657
Closed -$4.18M
FLO icon
171
Flowers Foods
FLO
$1.53B
-55,800
Closed -$1.05M
CEMP
172
DELISTED
Cempra, Inc.
CEMP
-64,550
Closed -$210K
CWBS
173
DELISTED
COMMONWEALTH BANKSHARES INC VA
CWBS
$0 ﹤0.01%
11,761
PSTB
174
DELISTED
Park Sterling Corp.
PSTB
-15,384
Closed -$191K

Similar funds

Franklin Street Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Franklin Street Advisors held 189 positions worth $668M, up 9.7% from $609M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Franklin Street Advisors's Q4 2017 filing shows 18 new, 76 increased, 37 reduced and 11 closed positions. Its largest new stake was IQVIA: 76,060 shares worth $7.45M. The largest sale was Monsanto Co, an estimated $8.89M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

  • Franklin Street Advisors's largest Q4 2017 buy was IQVIA: 76,060 shares worth $7.45M.
  • Franklin Street Advisors added most to Nike in Q4 2017, an estimated $2.98M increase.
  • Franklin Street Advisors's biggest Q4 2017 reduction was Monsanto Co, cutting an estimated $8.89M.
  • Franklin Street Advisors fully exited Clorox in Q4 2017, selling an estimated $4.18M.
  • Franklin Street Advisors's ten largest holdings make up 30% of its $668M portfolio in Q4 2017.
  • Franklin Street Advisors opened 18 new positions and closed 11 in Q4 2017.
  • Franklin Street Advisors's portfolio value rose 9.7% quarter-over-quarter to $668M.

Based on Franklin Street Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.